Reduction of phosphatidylinositol-4,5-bisphosphate mass in heart sarcolemma during diabetic cardiomyopathy.
Tappia
P S
PS
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada.
Liu
S Y
SY
Tong
Y
Y
Ssenyange
S
S
Panagia
V
V
D000818:Animals; D009202:Cardiomyopathies / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D003925:Diabetic Angiopathies / Q000378:metabolism*; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010084:Oxidation-Reduction; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012508:Sarcolemma / Q000378:metabolism*
D019269:Phosphatidylinositol 4,5-Diphosphate